Day: September 2, 2020

ANN ARBOR, Mich., Sept. 02, 2020 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR), today announced that members of Esperion management will participate in two upcoming virtual conferences during the month of September.A live audio webcast of the Morgan Stanley 18th Annual Global Healthcare Conference fireside chat can be accessed on the investor relations section of the Esperion website at www.esperion.com/investors-media/events-presentations/. Replay of the webcast will be archived on the Company’s website for 90 days following the event.Esperion TherapeuticsThrough scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at Esperion is committed to developing new LDL-C lowering medicines that will make a substantial impact on reducing global cardiovascular disease,...

WEST PALM BEACH, Fla., Sept. 02, 2020 (GLOBE NEWSWIRE) — Rennova Health, Inc. (OTC: RNVA) (OTC: RNVAW), today announced that on August 31, 2020, the Company completed agreements with certain institutional investors to reduce their holdings of the Company’s secured debentures by approximately $19.3 million by exchanging the debentures for shares of the Company’s newly-authorized Series N Convertible Redeemable Preferred Stock (the “Series N Preferred Stock”).The investors continue to own approximately $14.9 million of secured debentures, but have agreed that the Company could redeem $10 million of its obligations under these debentures within 90 days at which time the outstanding balance will also be exchanged to the Company’s Series N Preferred Stock.The investors exchanged approximately $19.3 million of debentures and all of the...

VANCOUVER, British Columbia, Sept. 02, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that it has now enrolled 50 patients in its multinational Phase 2b/3 human study of NP-120 (Ifenprodil) for the treatment of COVID-19.“We are very pleased with the enrollment rate considering we started the study less than 30 days ago,” said Christopher J. Moreau CEO of Algernon Pharmaceuticals. “We should see an increase in the number of patients enrolling per week as the study progresses.”Phase 2b/3 Study Protocol SummaryThe Company’s multinational Phase 2b/3 human trial for COVID-19 is entitled, “A Randomized Open Label Phase 2b/3 Study of the Safety and Efficacy of NP-120 (Ifenprodil)...

BEVERLY, Mass. and TORONTO, Sept. 02, 2020 (GLOBE NEWSWIRE) — Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that David Wolf, President and CEO of Hamilton Thorne Ltd., will deliver a virtual presentation at the upcoming H.C. Wainwright 22nd Annual Global Investment Conference on Tuesday, September 15, 2020 at 2:30 pm EDT. Mr. Wolf will also be available for virtual one-on-one meetings during the conference.About Hamilton Thorne Ltd. (www.hamiltonthorne.ltd)Hamilton Thorne is a leading global provider of precision instruments, consumables, software and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive...

BROOMFIELD, Colo., Sept. 02, 2020 (GLOBE NEWSWIRE) — Noodles & Company (NASDAQ: NDLS) today announced that the Company will participate in a virtual fireside chat discussion at the CL King’s 18th Annual Best Ideas conference. Noodles’ discussion will start at 10:15 am Eastern Time on Wednesday, September 16, 2020.This discussion will be webcast live and archived on the Noodles & Company website. To access the webcast, please visit www.noodles.com under the “Investor Relations” tab.About Noodles & CompanySince 1995, Noodles & Company has been serving noodles your way, with noodles and flavors that you know and love as well as new ones you’re about to discover. From indulgent Wisconsin Mac & Cheese to better-for-you Zoodles and Other Noodles, the company serves a world of flavor in every bowl. Made up...

AUSTIN, Texas, Sept. 02, 2020 (GLOBE NEWSWIRE) — Chuy’s Holdings, Inc. (NASDAQ:CHUY) today announced that the Company will participate in a virtual fireside chat discussion at the C.L. King’s 18th Annual Best Ideas Conference. Chuy’s discussion will start at 2:00 pm Eastern Time on Wednesday, September 16, 2020.The discussion will be webcast live and archived on the Chuy’s website. To access the webcast, please visit www.chuys.com under the “Investors” tab.About Chuy’sFounded in Austin, Texas in 1982, Chuy’s owns and operates full-service restaurants across 19 states serving a distinct menu of authentic, made from scratch Tex-Mex inspired dishes. Chuy’s highly flavorful and freshly prepared fare is served in a fun, eclectic and irreverent atmosphere, while each location offers a unique, “unchained” look and feel, as expressed by...

WALTHAM, Mass., Sept. 02, 2020 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system (CNS) disorders, today announced that it will participate in Citi’s 15th Annual BioPharma Virtual Conference on September 9, 2020 at 1:30 p.m. Eastern Time.  The panel in which the Company will participate is entitled “Emerging Therapies for Psychiatric Disorders.”The presentation will be webcast and accessible on a live and archived basis through the investor relations section of the Company’s web site, http://ir.minervaneurosciences.com.  About Minerva NeurosciencesMinerva’s portfolio of compounds includes: roluperidone (MIN-101), in clinical development for schizophrenia; a potential royalty stream from...

LOS ANGELES, Sept. 02, 2020 (GLOBE NEWSWIRE) — BlackLine, Inc. (Nasdaq: BL) today announced that BlackLine’s management team will participate in the following virtual investor conferences:

HOUSTON, Sept. 02, 2020 (GLOBE NEWSWIRE) — Sharps Compliance Corp. (Nasdaq: SMED) announced today that David P. Tusa, Chief Executive Officer has been invited to participate in Barrington Research’s 13th Annual Fall Investment Conference, which will take place virtually on Wednesday, September 9, 2020. Mr. Tusa will be available throughout the day for one-on-one and small group meetings via teleconference.About Sharps Compliance Corp.Headquartered in Houston, Texas, Sharps Compliance is a leading full-service national provider of comprehensive waste management services including medical, pharmaceutical and hazardous. Its key markets include healthcare facilities, pharmaceutical manufacturers, home healthcare providers, assisted living / long-term care, surgery centers, retail pharmacies and clinics, and the professional market which...

Highly Strategic Addition to Location & Inspection PlatformAttractive Growth Platform with Recurring Revenue Base in Robotics as a Service (RaaS)Significantly Enhances New Product Development CapabilitiesCHARLOTTE, N.C., Sept. 02, 2020 (GLOBE NEWSWIRE) — SPX Corporation (NYSE:SPXC) announced today that it has acquired ULC Robotics (“ULC”), a leading developer of robotic systems, machine learning applications and inspection technology for the energy, utility and industrial sectors.  A pioneer in the field of Robotics-as-a-Service (RaaS), ULC operates a growing, recurring-revenue business called CISBOT which uses robotic solutions designed to rehabilitate and extend the life of natural gas distribution networks for utility customers.  ULC also operates a custom Research & Development (“R&D”) business that provides cutting...